COURSE DESCRIPTION: 
Please join us for a conference on The Hidden Cost of Penicillin Allergy, with expert faculty Amy B. Schiffman, M.D., who will provide a comprehensive and clinically practical review of penicillin allergy evaluation and management. Through this session, clinicians will gain insight into the epidemiology and economic impact of penicillin allergy labeling, along with a focused review of the relevant immune mechanisms underlying beta-lactam hypersensitivity.

Dr. Schiffman will discuss the pathophysiology of penicillin and other beta-lactam allergies, outline current diagnostic testing procedures, and review the predictive value, safety, and efficacy of testing across key patient subpopulations. The course will also examine cephalosporin cross-reactivity and its implications for antibiotic prescribing in both inpatient and outpatient settings.

This activity is designed to equip physicians with evidence-based tools to more accurately assess penicillin allergy, optimize antimicrobial use, and improve patient care.


TARGET AUDIENCE:

Internal Medicine Physicians, Cardiologists, Pulmonologists, Oncologists, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Examine the epidemiology and cost of penicillin allergy
• Briefly review the immune system
• Appreciate the pathophysiology of beta lactam allergy
• Describe the testing procedures
• Discuss predictive value
• Evaluate efficacy and safety of testing in sub-populations
• Review cephalosporin cross reactivity
   

FACULTY AND DISCLOSURES:

Amy B. Schiffman, M.D.
Allergist
Allergy, Asthma, & Immunology Specialists 
Boca Raton, Florida

Amy B. Schiffman, M.D., faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

John F. Rubin, M.D., FACP, director for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-1296402, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Laboratory Personnel, Athletic Trainers and Respiratory Techs. Baptist Health South Florida CE Broker Provider #50-182.